The neurotoxic legacy of CAR-T cells: where do we stand?
Therapeutic Advances in Neurological Disorders
Published online on May 16, 2026
Abstract
Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Chimeric antigen receptor T (CAR-T) cell therapy has transformed outcomes for relapsed/refractory B-cell malignancies and is increasingly reshaping the therapeutic landscape of autoimmune disorders and solid tumors, offering curative potential where ...
Chimeric antigen receptor T (CAR-T) cell therapy has transformed outcomes for relapsed/refractory B-cell malignancies and is increasingly reshaping the therapeutic landscape of autoimmune disorders and solid tumors, offering curative potential where ...